Tag: cse:lxx
July 16, 2019
Hill Street CEO: Cannabis-infused and Alcohol-free Beverages will Disrupt the Industry
Hill Street Beverage Company CEO Terry Donnelly joined the Investing News Network to provide his views on the cannabis-infused beverages...
July 11, 2019
Lexaria Bioscience Enters CBD License Agreement with Universal Hemp
Lexaria Bioscience Enters CBD License Agreement with Universal Hemp July 10, 2019
Lexaria Bioscience Enters CBD Beverage License Agreement with Nic’s Beverages
Lexaria Bioscience Corp. (OTCQX:LXRP, CSE:LXX) (the “Company” or “Lexaria”), a drug delivery platform innovator, announces that it has entered a... June 4, 2019
Lexaria Bioscience Announces new DehydraTECH Innovation, Files New Patents
Lexaria Bioscience Corp. (CSE:LXX, OTCQX:LXRP)(the "Company" or "Lexaria"), a drug delivery platform innovator, has discovered improved performance characteristics of a... May 28, 2019
Combining Lexaria’s DehydraTECH(TM) with Nanotech Delivers Increased Quantities of CBD into Brain Tissue
Lexaria Bioscience Corp. (CSE:LXX, OTCQX:LXRP)) (the "Company" or "Lexaria"), a drug delivery platform innovator, announces recent animal testing proves that... May 21, 2019
Lexaria Bioscience and Nuka Enterprises’ 1906 Expand Cannabis Product Relationship
1906 fast-acting edibles products, powered by Lexaria's DehydraTECH technology, will expand across the US in 2019 and 2020 May 15, 2019